Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of NLRP3 Inflammasome Activation of Adipose Tissue in the Progression of Weight Loss After Sleeve Gastrectomy in Morbidly Obese Patients.

NCT04814147 is registered in ClinicalTrials.gov with University Hospital Center of Martinique as lead sponsor.

NCT NCT04814147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04814147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of NLRP3 Inflammasome Activation of Adipose Tissue in the Progression of Weight Loss After Sleeve Gastrectomy in Morbidly Obese Patients.
Lead sponsor
University Hospital Center of Martinique
Phase
Observational
Overall status
Unknown status
Start date
March 13, 2021
Completion date
June 12, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity morbid, obesity-associated insulin resistance